OFIX Fundamental Analysis - ORTHOFIX MEDICAL INC

Fundamental Rating

OFIX gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 190 industry peers in the Health Care Equipment & Supplies industry. OFIX may be in some trouble as it scores bad on both profitability and health. OFIX does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year OFIX has reported negative net income.

In the past year OFIX had a positive cash flow from operations.

OFIX had negative earnings in 4 of the past 5 years.

In multiple years OFIX reported negative operating cash flow during the last 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -14.78%, OFIX is in line with its industry, outperforming 55.26% of the companies in the same industry.

OFIX has a Return On Equity of -26.99%. This is comparable to the rest of the industry: OFIX outperforms 57.37% of its industry peers.

		Industry Rank	Sector Rank
ROA	-14.78%
ROE	-26.99%
ROIC	N/A

ROA(3y)-11.59%

ROA(5y)-8.47%

ROE(3y)-18.73%

ROE(5y)-13.37%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Gross Margin of OFIX (67.37%) is better than 73.68% of its industry peers.

In the last couple of years the Gross Margin of OFIX has declined.

OFIX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	67.37%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-3.19%

GM growth 5Y-2.65%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

OFIX does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, OFIX has more shares outstanding

Compared to 5 years ago, OFIX has more shares outstanding

OFIX has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 1.41, we must say that OFIX is in the distress zone and has some risk of bankruptcy.

With a Altman-Z score value of 1.41, OFIX perfoms like the industry average, outperforming 52.11% of the companies in the same industry.

OFIX has a debt to FCF ratio of 380.24. This is a negative value and a sign of low solvency as OFIX would need 380.24 years to pay back of all of its debts.

With a decent Debt to FCF ratio value of 380.24, OFIX is doing good in the industry, outperforming 65.79% of the companies in the same industry.

OFIX has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.

The Debt to Equity ratio of OFIX (0.38) is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0.38
Debt/FCF	380.24
Altman-Z	1.41

ROIC/WACCN/A

WACC7.76%

2.3 Liquidity

A Current Ratio of 2.67 indicates that OFIX has no problem at all paying its short term obligations.

With a Current ratio value of 2.67, OFIX perfoms like the industry average, outperforming 54.21% of the companies in the same industry.

A Quick Ratio of 1.50 indicates that OFIX should not have too much problems paying its short term obligations.

OFIX's Quick ratio of 1.50 is on the low side compared to the rest of the industry. OFIX is outperformed by 60.00% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.67
Quick Ratio	1.5

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for OFIX have decreased strongly by -4500.00% in the last year.

Measured over the past years, OFIX shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -63.14% on average per year.

OFIX shows a small growth in Revenue. In the last year, the Revenue has grown by 4.84%.

OFIX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.69% yearly.

EPS 1Y (TTM)-4500%

EPS 3Y-77.34%

EPS 5Y-63.14%

EPS Q2Q%-1000%

Revenue 1Y (TTM)4.84%

Revenue growth 3Y19.84%

Revenue growth 5Y11.69%

Sales Q2Q%2.27%

3.2 Future

Based on estimates for the next years, OFIX will show a very negative growth in Earnings Per Share. The EPS will decrease by -375.84% on average per year.

OFIX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.57% yearly.

EPS Next Y-22710.03%

EPS Next 2Y-1177.34%

EPS Next 3Y-375.84%

EPS Next 5YN/A

Revenue Next Year2.22%

Revenue Next 2Y3.89%

Revenue Next 3Y4.57%

Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OFIX. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OFIX. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, OFIX is valued a bit cheaper than 65.79% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	1390.29
EV/EBITDA	N/A

4.3 Compensation for Growth

A cheap valuation may be justified as OFIX's earnings are expected to decrease with -375.84% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-1177.34%

EPS Next 3Y-375.84%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for OFIX!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

ORTHOFIX MEDICAL INC

NASDAQ:OFIX (10/22/2025, 8:00:02 PM)

After market: 16.23 0 (0%)

16.23

+0.51 (+3.24%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)08-05 2025-08-05/bmo

Earnings (Next)11-04 2025-11-04/amc

Inst Owners91.86%

Inst Owner Change-0.18%

Ins Owners1.41%

Ins Owner Change4.93%

Market Cap640.92M

Revenue(TTM)809.03M

Net Income(TTM)-123709000

Analysts83.64

Price Target23 (41.71%)

Short Float %4.35%

Short Ratio4.11

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)45.08%

Min EPS beat(2)9.96%

Max EPS beat(2)80.19%

EPS beat(4)4

Avg EPS beat(4)93.78%

Min EPS beat(4)9.96%

Max EPS beat(4)145.75%

EPS beat(8)8

Avg EPS beat(8)102.6%

EPS beat(12)12

Avg EPS beat(12)91.27%

EPS beat(16)13

Avg EPS beat(16)59.5%

Revenue beat(2)1

Avg Revenue beat(2)0.24%

Min Revenue beat(2)-0.65%

Max Revenue beat(2)1.14%

Revenue beat(4)1

Avg Revenue beat(4)-0.51%

Min Revenue beat(4)-1.92%

Max Revenue beat(4)1.14%

Revenue beat(8)3

Avg Revenue beat(8)-0.52%

Revenue beat(12)4

Avg Revenue beat(12)-1.82%

Revenue beat(16)4

Avg Revenue beat(16)-1.78%

PT rev (1m)0%

PT rev (3m)1.12%

EPS NQ rev (1m)0%

EPS NQ rev (3m)-3.61%

EPS NY rev (1m)15.61%

EPS NY rev (3m)7.06%

Revenue NQ rev (1m)0.03%

Revenue NQ rev (3m)-0.51%

Revenue NY rev (1m)-0.05%

Revenue NY rev (3m)0.17%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.79
P/FCF	1390.29
P/OCF	22.37
P/B	1.4
P/tB	3.47
EV/EBITDA	N/A

EPS(TTM)-0.44

EYN/A

EPS(NY)-1.61

Fwd EYN/A

FCF(TTM)0.01

FCFY0.07%

OCF(TTM)0.73

OCFY4.47%

SpS20.49

BVpS11.61

TBVpS4.67

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-14.78%
ROE	-26.99%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	67.37%
FCFM	0.06%

ROA(3y)-11.59%

ROA(5y)-8.47%

ROE(3y)-18.73%

ROE(5y)-13.37%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-3.19%

GM growth 5Y-2.65%

F-Score5

Asset Turnover0.97

Health

		Industry Rank	Sector Rank
Debt/Equity	0.38
Debt/FCF	380.24
Debt/EBITDA	N/A
Cap/Depr	34.18%
Cap/Sales	3.48%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.67
Quick Ratio	1.5
Altman-Z	1.41

F-Score5

WACC7.76%

ROIC/WACCN/A

Cap/Depr(3y)86.5%

Cap/Depr(5y)81.89%

Cap/Sales(3y)6%

Cap/Sales(5y)5.69%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-4500%

EPS 3Y-77.34%

EPS 5Y-63.14%

EPS Q2Q%-1000%

EPS Next Y-22710.03%

EPS Next 2Y-1177.34%

EPS Next 3Y-375.84%

EPS Next 5YN/A

Revenue 1Y (TTM)4.84%

Revenue growth 3Y19.84%

Revenue growth 5Y11.69%

Sales Q2Q%2.27%

Revenue Next Year2.22%

Revenue Next 2Y3.89%

Revenue Next 3Y4.57%

Revenue Next 5YN/A

EBIT growth 1Y1.46%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year202.59%

EBIT Next 3Y49.93%

EBIT Next 5YN/A

FCF growth 1Y100.61%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y174.61%

OCF growth 3Y11.71%

OCF growth 5Y-4.22%

ORTHOFIX MEDICAL INC (OFIX) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens